The Latest Cardiac and Vascular News
15 Grantees Awarded Nearly $500,000 in Final 2020 Application Round CHELMSFORD, Mass.–(BUSINESS WIRE)–In the application round ended September 30, 2020, the ZOLL Foundation, established in 2014 to support young investigators through research grants in the fields of resuscitation and acute critical care, received 35 applications from across the United States, […]
CHELMSFORD, Mass.–(BUSINESS WIRE)–ZOLL® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, announced today that the ZOLL AED 3® defibrillator received premarket approval (PMA) by the FDA for use by lay rescuers. “ZOLL is committed to supporting the public with all emergency preparedness needs during this […]
CHELMSFORD, Mass.–(BUSINESS WIRE)–ZOLL® Medical Corporation, an Asahi Kasei Group company that manufactures medical devices and related software solutions, announced the return of funds it received from the Department of Health and Human Services (HHS) as part of the CARES Act Provider Relief Fund. The CARES Act Provider Relief Fund allocated […]
May 4, 2020 — CHELMSFORD, MASS. — ZOLL® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, announced today it has received CE Mark approval to market and distribute its SuperSaturated Oxygen (SSO2) Therapy System in Europe. SSO2 Therapy provides interventional cardiologists with the first and only clinically proven […]
First and Only Treatment to Reduce Heart Muscle Damage Following Angioplasty and Stenting CHELMSFORD, Mass.–(BUSINESS WIRE)–ZOLL® Medical Corporation, an Asahi Kasei Group company that manufactures medical devices and related software solutions, announced today it has received U.S. Food and Drug Administration (FDA) approval of the second-generation TherOx System, which provides SuperSaturated […]
Expands Solutions for Cardiac Arrest Victims in the Community CHELMSFORD, Mass.–(BUSINESS WIRE)–ZOLL Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, today confirmed that it has completed the previously announced acquisition of Cardiac Science® Corporation, a leading provider of automated external defibrillators (AEDs), related […]
CHELMSFORD, Mass.–(BUSINESS WIRE)–ZOLL® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, today announced it has acquired substantially all of the assets of Mobilize RRS LLC., of Pittsford, N.Y., a privately held company that markets the Mobilize Rescue Systems app and associated rescue kits, which are designed […]
CHELMSFORD, Mass.–(BUSINESS WIRE)–ZOLL® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, today announced it has acquired TherOx, Inc., of Irvine, Calif., a privately held company. TherOx is focused on improving treatment of acute myocardial infarction (AMI) and markets systems to deliver SuperSaturated Oxygen (SSO2) […]
LOS ANGELES, June 11, 2019 /PRNewswire/ — Aurora Resurgence, a Los Angeles-based private equity firm, today announced that its affiliate has entered into a definitive agreement to sell Cardiac Science Corporation (“Cardiac Science” or “CSC”), a leading provider of automated external defibrillators (“AEDs”), related services and accessories, to ZOLL® Medical Corporation, an Asahi Kasei […]
CHELMSFORD, Mass.–(BUSINESS WIRE)–ZOLL® Medical Corporation, an Asahi Kasei Group company that manufactures medical devices and related software solutions, announced the launch of and first patient prescription for the ZOLL µCor™ (pronounced “Micro Core”) Heart Failure and Arrhythmia Management System (HFAMS), designed to help clinicians improve outcomes and reduce hospitalizations for […]
